Promotion, Advertising & Exhibits
Stay up to date on regulatory news with ILCN, including @FDAOncology approvals of two combinations for #NSCLC treatment: #LCSMRead More
MET exon 14 skipping mutations occur in 3-4% of patients w/#NSCLC, typically in the absence of other driver mutations. Host @NarjustFlorezMD discusses the unique clinical issues surrounding MET exon with Dr. Ross Camidge & @NReguart. Listen Now: #LCSM https://t.co/9cwke7ynJ4Read More
The IASLC 2023 Latin America Conference on Lung Cancer (LALCA 2023) offers a tremendous opportunity to market to one of the leading gatherings of researchers, clinicians, and professionals in the field of lung cancer and thoracic oncology.
For information regarding promotion & advertising, symposia and exhibit opportunities, please contact:
International Association for the Study of Lung Cancer (IASLC)
Phone: +1 720 598 1951
Fax: +1 720 325 2848